TNF Pharmaceuticals Acquires Exclusive Rights to Light Speed Computing Accelerator.
PorAinvest
martes, 2 de septiembre de 2025, 9:35 am ET1 min de lectura
TNFA--
LightSolver's Laser Processing Unit (LPU) harnesses light for computation, offering an accelerated method that can solve complex problems at the speed of light. This technology is set to reduce energy costs by up to 90% in cryptocurrency applications, potentially transforming the industry's sustainability [1].
The partnership between TNF and LightSolver is supported by a strategic investment from TNF's largest stockholder, enabling the company to pursue a name change to reflect its new direction. TNF plans to leverage this technology to develop a scalable solution for cryptocurrency infrastructure, aiming to reduce energy consumption and enhance computational efficiency [1].
TNF Pharmaceuticals has also entered into a $7.0 million private placement financing agreement, involving the sale of 7,000 shares of its Series H convertible preferred stock. This funding will support the commercialization and development strategy for the licensed technology [1].
LightSolver, a 2025 World Economic Forum Technology Pioneer, has drawn significant attention for its breakthrough innovation. The company's technology has been recognized by Gartner as a sample vendor in the 2025 Hype Cycle for Data Center Infrastructure Technologies [1].
TNF Pharmaceuticals is positioned to capitalize on the growing momentum behind photonic computing and the future of cryptocurrency infrastructure. The company believes it holds first-mover advantages in this burgeoning industry, setting it up for growth and value creation [1].
References:
[1] https://www.morningstar.com/news/business-wire/20250902945912/tnf-pharmaceuticals-secures-exclusive-global-rights-to-innovative-light-speed-computing-accelerator-for-use-in-cryptocurrency-applications
TNF Pharmaceuticals has acquired exclusive global rights to an innovative light-based computing accelerator for use in cryptocurrency applications. The system, designed by LightSolver, outperforms quantum and supercomputing and solves complex problems unfeasible for GPUs. Supported by a strategic investment from TNF's largest stockholder, the company plans to pursue a name change to reflect its new direction.
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) has secured exclusive global rights to an innovative light-based computing accelerator developed by LightSolver Ltd. This technology, designed to outperform quantum and supercomputing systems, is poised to revolutionize cryptocurrency applications [1].LightSolver's Laser Processing Unit (LPU) harnesses light for computation, offering an accelerated method that can solve complex problems at the speed of light. This technology is set to reduce energy costs by up to 90% in cryptocurrency applications, potentially transforming the industry's sustainability [1].
The partnership between TNF and LightSolver is supported by a strategic investment from TNF's largest stockholder, enabling the company to pursue a name change to reflect its new direction. TNF plans to leverage this technology to develop a scalable solution for cryptocurrency infrastructure, aiming to reduce energy consumption and enhance computational efficiency [1].
TNF Pharmaceuticals has also entered into a $7.0 million private placement financing agreement, involving the sale of 7,000 shares of its Series H convertible preferred stock. This funding will support the commercialization and development strategy for the licensed technology [1].
LightSolver, a 2025 World Economic Forum Technology Pioneer, has drawn significant attention for its breakthrough innovation. The company's technology has been recognized by Gartner as a sample vendor in the 2025 Hype Cycle for Data Center Infrastructure Technologies [1].
TNF Pharmaceuticals is positioned to capitalize on the growing momentum behind photonic computing and the future of cryptocurrency infrastructure. The company believes it holds first-mover advantages in this burgeoning industry, setting it up for growth and value creation [1].
References:
[1] https://www.morningstar.com/news/business-wire/20250902945912/tnf-pharmaceuticals-secures-exclusive-global-rights-to-innovative-light-speed-computing-accelerator-for-use-in-cryptocurrency-applications
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema
Comentarios
Aún no hay comentarios